TWO-YEAR CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17 RECEPTOR ANTIBODY, IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：2
|
作者：
Mease, P. [1 ,2 ]
Genovese, M. C. [3 ]
Greenwald, M. W. [4 ]
Ritchlin, C. T. [5 ]
Beaulieu, A. [6 ]
Deodhar, A. [7 ]
Newmark, R. [8 ]
Feng, J. [8 ]
Erondu, N. [8 ]
Nirula, A. [8 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Desert Med Adv, Palm Desert, OH USA
[5] Univ Rochester, Med Ctr, Rochester, OH USA
[6] Univ Laval, Laval, PQ, Canada
[7] Oregon Hlth & Sci Univ, Portland, OR USA
[8] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3489
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0175
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [21] Two-year data: Infliximab maintains clinical response in psoriatic arthritis patients - An analysis of the year 2 data from the infliximab multinational psoriatic arthritis controlled trial (impact)
    Antoni, CE
    Kavanaugh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, D
    Weisman, MH
    Kalden, JR
    Smolen, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 82 - 82
  • [22] Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis
    Ndongo-Thiam, Ndieme
    Clement, Alice
    Pin, Jean-Jacques
    Razanajaona-Doll, Diane
    Miossec, Pierre
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1420 - U217
  • [23] Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis
    Chen, Yan
    Qian, Tian
    Zhang, Dongmei
    Yan, Heng
    Hao, Fei
    IMMUNOTHERAPY, 2015, 7 (09) : 1023 - 1037
  • [24] Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
    van Baarsen, Lisa G. M.
    Lebre, Maria C.
    van der Coelen, Dennis
    Aarrass, Saida
    Tang, Man W.
    Ramwadhdoebe, Tamara H.
    Gerlag, Danielle M.
    Tak, Paul P.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (04)
  • [25] Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
    Lisa GM van Baarsen
    Maria C Lebre
    Dennis van der Coelen
    Saïda Aarrass
    Man W Tang
    Tamara H Ramwadhdoebe
    Daniëlle M Gerlag
    Paul P Tak
    Arthritis Research & Therapy, 16
  • [26] A Phase Ib Multiple Ascending Dose Study Evaluating Safety, Pharmacokinetics, and Early Clinical Response of Brodalumab (AMG 827), a Human Anti-Interleukin 17 Receptor (IL-17R) Antibody, in Rheumatoid Arthritis
    Churchill, Melvin A.
    Flores-Suarez, Luis F.
    Wallace, Daniel J.
    Phillips, Kristine
    Martin, Richard W.
    Cardiel, Mario H.
    Kaine, Jeffrey
    Bautista, Edgar
    Salinger, David H.
    Stevens, Erin
    Russell, Christopher B.
    Martin, David A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S555 - S555
  • [27] Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis
    Bai, Fuliang
    Tian, Hui
    Niu, Zeshan
    Liu, Mingyao
    Ren, Guiping
    Yu, Yinhang
    Sun, Tian
    Li, Siming
    Li, Deshan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (03) : 711 - 721
  • [28] Clinical pharmacology of anti-il-17 receptor antibody khk4827 (brodalumab) in Japanese healthy volunteers and subjects with moderate to severe psoriasis: a randomized, dose-escalation, placebo-controlled study
    Nemoto, O.
    Nagashima, H.
    Sayama, K.
    Kobayashi, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 21 - 22
  • [29] Regarding Mastorino et al.'s 'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'
    Yu, Sebastian
    Wei, James Cheng-Chung
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1388 - E1389
  • [30] PRELIMINARY RESULTS OF A TWO-YEAR FOLLOW UP OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Vergara-Dangond, C.
    Robustillo-Villarino, M.
    Nunez-Monje, V.
    Aguilar-Zamora, M.
    Montolio-Chiva, L.
    Valls-Pascual, E.
    Ybanez-Garcia, A.
    Martinez-Ferrer, A.
    Alegre-Sancho, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1316 - 1316
12345